{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:11:24Z","timestamp":1784077884479,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1261-x","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T09:05:08Z","timestamp":1551431108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-5711","authenticated-orcid":false,"given":"Josefin","family":"M\u00f6rtberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lundwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Mobarrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Wall\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Spaak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"issue":"17","key":"1261_CR1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. Jama. 2007;298(17):2038\u201347.","journal-title":"Jama."},{"issue":"4","key":"1261_CR2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.2016121374","volume":"28","author":"J Coresh","year":"2017","unstructured":"Coresh J. Update on the burden of CKD. J Am Soc Nephrol. 2017;28(4):1020\u20132.","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"1261_CR3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305.","journal-title":"N Engl J Med"},{"issue":"9844","key":"1261_CR4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","volume":"380","author":"M Tonelli","year":"2012","unstructured":"Tonelli M, Muntner P, Lloyd A, Manns BJ, Klarenbach S, Pannu N, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet (London, England). 2012;380(9844):807\u201314.","journal-title":"Lancet (London, England)"},{"issue":"13","key":"1261_CR5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","volume":"351","author":"NS Anavekar","year":"2004","unstructured":"Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285\u201395.","journal-title":"N Engl J Med"},{"issue":"4","key":"1261_CR6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/STROKEAHA.108.520882","volume":"40","author":"G Yahalom","year":"2009","unstructured":"Yahalom G, Schwartz R, Schwammenthal Y, Merzeliak O, Toashi M, Orion D, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke. 2009;40(4):1296\u2013303.","journal-title":"Stroke."},{"issue":"2","key":"1261_CR7","doi-asserted-by":"crossref","first-page":"e000707","DOI":"10.1161\/JAHA.113.000707","volume":"3","author":"M Holzmann","year":"2014","unstructured":"Holzmann M, Jernberg T, Szummer K, Sartipy U. Long-term cardiovascular outcomes in patients with chronic kidney disease undergoing coronary artery bypass graft surgery for acute coronary syndromes. J Am Heart Assoc. 2014;3(2):e000707.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1261_CR8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","volume":"3","author":"P Stenvinkel","year":"2008","unstructured":"Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol. 2008;3(2):505\u201321.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"1261_CR9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfv358","volume":"31","author":"S Zewinger","year":"2016","unstructured":"Zewinger S, Schumann T, Fliser D, Speer T. Innate immunity in CKD-associated vascular diseases. Nephrol Dial Transplant. 2016;31(11):1813\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1261_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MBC.0000000000000462","volume":"27","author":"J Mortberg","year":"2016","unstructured":"Mortberg J, Blomback M, Wallen A, He S, Jacobson SH, Spaak J. Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease. Blood Coagul Fibrinolysis. 2016;27(4):401\u20137.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"1261_CR11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1378\/chest.08-1425","volume":"135","author":"S Manzano-Fernandez","year":"2009","unstructured":"Manzano-Fernandez S, Marin F, Pastor-Perez FJ, Caro C, Cambronero F, Lacunza J, et al. Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting. Chest. 2009;135(4):983\u201390.","journal-title":"Chest."},{"issue":"3","key":"1261_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"CS Fox","year":"2010","unstructured":"Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and intervention outcomes network registry. Circulation. 2010;121(3):357\u201365.","journal-title":"Circulation"},{"issue":"7","key":"1261_CR13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/2047487317693950","volume":"24","author":"M Khedri","year":"2017","unstructured":"Khedri M, Szummer K, Carrero JJ, Jernberg T, Evans M, Jacobson SH, et al. Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function. Eur J Prev Cardiol. 2017;24(7):724\u201334.","journal-title":"Eur J Prev Cardiol"},{"key":"1261_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fphar.2016.00293","volume":"7","author":"L Badimon","year":"2016","unstructured":"Badimon L, Suades R, Fuentes E, Palomo I, Padro T. Role of platelet-derived microvesicles as crosstalk mediators in Atherothrombosis and future pharmacology targets: a link between inflammation, atherosclerosis, and thrombosis. Front Pharmacol. 2016;7:293.","journal-title":"Front Pharmacol"},{"issue":"7","key":"1261_CR15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/CS20120309","volume":"124","author":"D Burger","year":"2013","unstructured":"Burger D, Schock S, Thompson CS, Montezano AC, Hakim AM, Touyz RM. Microparticles: biomarkers and beyond. Clin Sci (Lond). 2013;124(7):423\u201341.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"1261_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2015010074","volume":"27","author":"U Erdbrugger","year":"2016","unstructured":"Erdbrugger U, Le TH. Extracellular vesicles in renal diseases: more than novel biomarkers? J Am Soc Nephrol. 2016;27(1):12\u201326.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1261_CR17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH06-06-0313","volume":"97","author":"EI Sinauridze","year":"2007","unstructured":"Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97(3):425\u201334.","journal-title":"Thromb Haemost"},{"issue":"4","key":"1261_CR18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000438782","volume":"132","author":"WQ Han","year":"2015","unstructured":"Han WQ, Chang FJ, Wang QR, Pan JQ. Microparticles from patients with the acute coronary syndrome impair vasodilatation by inhibiting the Akt\/eNOS-Hsp90 signaling pathway. Cardiology. 2015;132(4):252\u201360.","journal-title":"Cardiology."},{"issue":"1","key":"1261_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.32326","volume":"23","author":"S Nomura","year":"2016","unstructured":"Nomura S. Microparticle and Atherothrombotic diseases. J Atheroscler Thromb. 2016;23(1):1\u20139.","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"1261_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrcardio.2017.7","volume":"14","author":"CM Boulanger","year":"2017","unstructured":"Boulanger CM, Loyer X, Rautou PE, Amabile N. Extracellular vesicles in coronary artery disease. Nat Rev Cardiol. 2017;14(5):259\u201372.","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"1261_CR21","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1160\/TH12-07-0486","volume":"108","author":"R Suades","year":"2012","unstructured":"Suades R, Padro T, Vilahur G, Badimon L. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost. 2012;108(6):1208\u201319.","journal-title":"Thromb Haemost"},{"issue":"3","key":"1261_CR22","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1016\/j.thromres.2010.05.023","volume":"126","author":"S Tehrani","year":"2010","unstructured":"Tehrani S, Mobarrez F, Antovic A, Santesson P, Lins PE, Adamson U, et al. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Thromb Res. 2010;126(3):e225\u201331.","journal-title":"Thromb Res"},{"issue":"4","key":"1261_CR23","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/ndt\/gfr474","volume":"27","author":"MC Trappenburg","year":"2012","unstructured":"Trappenburg MC, van Schilfgaarde M, Frerichs FC, Spronk HM, ten Cate H, de Fijter CW, et al. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. Nephrol Dial Transplant. 2012;27(4):1446\u201353.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1261_CR24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/bph.13517","volume":"174","author":"A Daiber","year":"2017","unstructured":"Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I, et al. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017;174(12):1591\u2013619.","journal-title":"Br J Pharmacol"},{"key":"1261_CR25","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8514056","volume":"2016","author":"KR Paudel","year":"2016","unstructured":"Paudel KR, Panth N, Kim DW. Circulating endothelial microparticles: a key Hallmark of atherosclerosis progression. Scientifica. 2016;2016:8514056.","journal-title":"Scientifica."},{"issue":"11","key":"1261_CR26","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1681\/ASN.2005050535","volume":"16","author":"N Amabile","year":"2005","unstructured":"Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16(11):3381\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1261_CR27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/eurjhf\/hfq145","volume":"12","author":"T Nozaki","year":"2010","unstructured":"Nozaki T, Sugiyama S, Sugamura K, Ohba K, Matsuzawa Y, Konishi M, et al. Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail. 2010;12(11):1223\u20138.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1261_CR28","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/ndt\/gfr573","volume":"27","author":"N Amabile","year":"2012","unstructured":"Amabile N, Guerin AP, Tedgui A, Boulanger CM, London GM. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant. 2012;27(5):1873\u201380.","journal-title":"Nephrol Dial Transplant"},{"issue":"16","key":"1261_CR29","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/ehq478","volume":"32","author":"JM Sinning","year":"2011","unstructured":"Sinning JM, Losch J, Walenta K, Bohm M, Nickenig G, Werner N. Circulating CD31+\/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32(16):2034\u201341.","journal-title":"Eur Heart J"},{"issue":"9","key":"1261_CR30","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.clinbiochem.2015.02.003","volume":"48","author":"A Berezin","year":"2015","unstructured":"Berezin A, Zulli A, Kerrigan S, Petrovic D, Kruzliak P. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin Biochem. 2015;48(9):562\u20138.","journal-title":"Clin Biochem"},{"issue":"6","key":"1261_CR31","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1160\/TH11-11-0779","volume":"107","author":"M Skeppholm","year":"2012","unstructured":"Skeppholm M, Mobarrez F, Malmqvist K, Wallen H. Platelet-derived microparticles during and after acute coronary syndrome. Thromb Haemost. 2012;107(6):1122\u20139.","journal-title":"Thromb Haemost"},{"key":"1261_CR32","doi-asserted-by":"crossref","unstructured":"Ye S, Shan XF, Han WQ, Zhang QR, Gao J, Jin AP, et al. Microparticles from patients undergoing percutaneous coronary intervention impair vasodilatation by uncoupling endothelial nitric oxide synthase. Shock (Augusta, Ga). 2017;48(2):201\u2013208.","DOI":"10.1097\/SHK.0000000000000823"},{"issue":"1","key":"1261_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2014.07.022","volume":"176","author":"G Giannopoulos","year":"2014","unstructured":"Giannopoulos G, Oudatzis G, Paterakis G, Synetos A, Tampaki E, Bouras G, et al. Red blood cell and platelet microparticles in myocardial infarction patients treated with primary angioplasty. Int J Cardiol. 2014;176(1):145\u201350.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1261_CR34","doi-asserted-by":"crossref","first-page":"e0172558","DOI":"10.1371\/journal.pone.0172558","volume":"12","author":"G Chiva-Blanch","year":"2017","unstructured":"Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, et al. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity. PLoS One. 2017;12(2):e0172558.","journal-title":"PLoS One"},{"issue":"1","key":"1261_CR35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2011.12.025","volume":"221","author":"C Jung","year":"2012","unstructured":"Jung C, Sorensson P, Saleh N, Arheden H, Ryden L, Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis. 2012;221(1):226\u201331.","journal-title":"Atherosclerosis"},{"issue":"8","key":"1261_CR36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1160\/TH16-11-0837","volume":"117","author":"C Christersson","year":"2017","unstructured":"Christersson C, Thulin A, Siegbahn A. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events. Thromb Haemost. 2017;117(8):1571\u201381.","journal-title":"Thromb Haemost"},{"issue":"11","key":"1261_CR37","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jacc.2009.10.043","volume":"55","author":"DJ Angiolillo","year":"2010","unstructured":"Angiolillo DJ, Bernardo E, Capodanno D, Vivas D, Sabate M, Ferreiro JL, et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol. 2010;55(11):1139\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1261_CR38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2005080834","volume":"17","author":"F Stam","year":"2006","unstructured":"Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006;17(2):537\u201345.","journal-title":"J Am Soc Nephrol"},{"key":"1261_CR39","first-page":"9035193","volume":"2017","author":"NC Chen","year":"2017","unstructured":"Chen NC, Hsu CY, Chen CL. The strategy to prevent and regress the vascular calcification in Dialysis patients. Biomed Res Int. 2017;2017:9035193.","journal-title":"Biomed Res Int"},{"key":"1261_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.11.083","volume":"77","author":"C Palombo","year":"2016","unstructured":"Palombo C, Kozakova M. Arterial stiffness, atherosclerosis and cardiovascular risk: pathophysiologic mechanisms and emerging clinical indications. Vasc Pharmacol. 2016;77:1\u20137.","journal-title":"Vasc Pharmacol"},{"issue":"11","key":"1261_CR41","doi-asserted-by":"crossref","first-page":"F1302","DOI":"10.1152\/ajprenal.00114.2014","volume":"307","author":"S Soriano","year":"2014","unstructured":"Soriano S, Carmona A, Trivino F, Rodriguez M, Alvarez-Benito M, Martin-Malo A, et al. Endothelial damage and vascular calcification in patients with chronic kidney disease. Am J Physiol Renal Physiol. 2014;307(11):F1302\u201311.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"1261_CR42","first-page":"344","volume":"106","author":"F Mobarrez","year":"2011","unstructured":"Mobarrez F, He S, Broijersen A, Wiklund B, Antovic A, Antovic J, et al. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost. 2011;106(2):344\u201352.","journal-title":"Thromb Haemost"},{"issue":"6","key":"1261_CR43","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/ndt\/gfv337","volume":"31","author":"T Almquist","year":"2016","unstructured":"Almquist T, Mobarrez F, Jacobson SH, Wallen H, Hjemdahl P. Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. Nephrol Dial Transplant. 2016;31(6):944\u201352.","journal-title":"Nephrol Dial Transplant"},{"key":"1261_CR44","doi-asserted-by":"crossref","unstructured":"Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension (Dallas, Tex : 1979) 2003;41(2):211\u2013217.","DOI":"10.1161\/01.HYP.0000049760.15764.2D"},{"issue":"2","key":"1261_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/heart.84.2.137","volume":"84","author":"WS Leslie","year":"2000","unstructured":"Leslie WS, Urie A, Hooper J, Morrison CE. Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care. Heart. 2000;84(2):137\u201341.","journal-title":"Heart"},{"issue":"2","key":"1261_CR46","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.atherosclerosis.2008.10.039","volume":"204","author":"O Morel","year":"2009","unstructured":"Morel O, Pereira B, Averous G, Faure A, Jesel L, Germain P, et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis. 2009;204(2):636\u201341.","journal-title":"Atherosclerosis."},{"issue":"2","key":"1261_CR47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.atherosclerosis.2013.01.032","volume":"227","author":"PK Min","year":"2013","unstructured":"Min PK, Kim JY, Chung KH, Lee BK, Cho M, Lee DL, et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis. 2013;227(2):323\u20138.","journal-title":"Atherosclerosis."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1261-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T19:09:36Z","timestamp":1582916976000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1261-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1261-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Regional Ethics committee of Stockholm, Sweden, approved the study Dnr 2017\/759\u201331. Verbal and written informed consent was obtained from all participants in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. The results presented in this paper have not been published previously in whole or part, except in abstract format. None of the contribution authors have any conflict of interests do declare pertinent the present paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"71"}}